Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lack of effect of atenolol on antipyrine clearance.

Literature DB >> 7138755

Lack of effect of atenolol on antipyrine clearance.

G T Tucker, N D Bax, M S Lennard, K Crewe, H F Woods.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1982 PMID： 7138755 PMCID： PMC1427474 DOI： 10.1111/j.1365-2125.1982.tb04967.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

4 in total

1. Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.

Authors: C S Deacon; M S Lennard; N D Bax; H F Woods; G T Tucker
Journal: Br J Clin Pharmacol Date: 1981-09 Impact factor: 4.335

2. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

Authors: N D Bax; M S Lennard; G T Tucker
Journal: Br J Clin Pharmacol Date: 1981-12 Impact factor: 4.335

3. The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.

Authors: T K Daneshmend; C J Roberts
Journal: Br J Clin Pharmacol Date: 1982-06 Impact factor: 4.335

4. Impairment of antipyrine clearance in humans by propranolol.

Authors: D J Greenblatt; K Franke; D H Huffman
Journal: Circulation Date: 1978-06 Impact factor: 29.690

4 in total

15 in total

1. Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance.

Authors: H Perrild; L Kayser; H E Poulsen; L Skovsted; B Jørgensen; J M Hansen
Journal: Br J Clin Pharmacol Date: 1989-11 Impact factor: 4.335

2. Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Authors: G T Tucker; N D Bax; M S Lennard; S Al-Asady; H S Bharaj; H F Woods
Journal: Br J Clin Pharmacol Date: 1984 Impact factor: 4.335

3. The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.

Authors: N D Bax; M S Lennard; G T Tucker; H F Woods; N R Porter; R G Malia; F E Preston
Journal: Br J Clin Pharmacol Date: 1984 Impact factor: 4.335

Review 4. Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors: R V Lewis; D G McDevitt
Journal: Med Toxicol Date: 1986 Sep-Oct

5. The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.

Authors: N D Bax; M S Lennard; G T Tucker; H F Woods; N R Porter; R G Malia; F E Preston
Journal: Br J Clin Pharmacol Date: 1984-05 Impact factor: 4.335

6. Lack of effect of atenolol on the pharmacokinetics of theophylline.

Authors: L A Cerasa; J S Bertino; E A Ludwig; M Savliwala; E Middleton; R L Slaughter
Journal: Br J Clin Pharmacol Date: 1988-12 Impact factor: 4.335

7. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.

Authors: B K Park
Journal: Br J Clin Pharmacol Date: 1984 Impact factor: 4.335

8. Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors: J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal: Br J Clin Pharmacol Date: 1984 Impact factor: 4.335

9. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.

Authors: D Gangji; M Juvent; G Niset; M Wathieu; M Degreve; R Bellens; J Poortmans; S Degre; T J Fitzsimons; A Herchuelz
Journal: Br J Clin Pharmacol Date: 1984 Impact factor: 4.335

10. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.

Authors: N D Bax; R W Jones; M S Lennard; G T Tucker; H F Woods
Journal: Br J Clin Pharmacol Date: 1985-05 Impact factor: 4.335